To determine whether PRMT5 and EZH2 co-localized in CRC cells, we performed immunofluorescence staining with anti-PRMT5 and anti-EZH2 antibodies in HCT116 and SW480 cells. Here, EZH2 is linked to colorectal carcinoma.